LAUSR

421Background: Major oncology societies outline different recommendations following curative intent treatment for pancreas cancer and this has resulted in wide variations in practice among institutions. We aim to describe patterns of surveillance and evaluate their impact on outcomes. Methods: A total of 147 adult patients who received at least one cycle of adjuvant chemotherapy with gemcitabine or 5-fluorouracil monotherapy at any of the British Columbia Cancer Agency centers between 2004 and 2015 were included in this analysis. Surveillance strategies were divided into two groups: discharged to primary care physicians (PCP) or follow up with oncologists that included regular clinical assessments, laboratory testing and/or diagnostic imaging. Results: Median age at diagnosis was 64 (range 38-85) years and 48% were men. More patients were followed by oncologists than PCP (66% vs. 44%). Among the measured prognostic factors, only patients with advanced tumor stage (T3/4) were more likely to be followed by ...